Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma
about
Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myelomaGene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myelomaAssessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry.Immunophenotypic studies of monoclonal gammopathy of undetermined significanceFlow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis.Teriparatide treatment complicated by malignant myelomaPathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma.Immunohistochemical evaluation of CD20 expression in patients with multiple myelomaMyelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications.Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells.Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality.The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in OncologyFlow Cytometry in Diagnosis of Myelomatous Pleural Effusion: A Case Report.Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyCurrent trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies.Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients.Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases.Immunophenotyping in multiple myeloma and related plasma cell disorders.Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myelomaImmunotherapies targeting CD38 in Multiple Myeloma.Flow cytometry method as a diagnostic tool for pleural fluid involvement in a patient with multiple myeloma.Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells.Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation methodCytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cellsExpression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiationPhenotypic consensus markers for plasma cell myeloma.Myelomatous plasma cells display an aberrant gene expression pattern similar to that observed in normal memory B cells.Current applications of multiparameter flow cytometry in plasma cell disorders.Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry.Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.
P2860
Q24619589-58586D6F-6EDA-42E0-AEAF-AF7B6970B81BQ28248800-638AD54E-7195-4D55-94C6-84BCF2F55200Q33294938-EAA11CE3-DAFA-4903-B90F-FD88851EF719Q33387979-5256C3F5-08AA-4CB6-916A-AD9B9FD17EA7Q33598391-1551B818-768F-4424-8F61-46476D821CA3Q34523230-D7BB02E8-613D-4D55-813A-3B3CAC137421Q34580260-E31FB4E6-B808-4DF6-B737-1338B284FBDAQ35054893-BF13735C-71A8-4D28-AA71-DCAD0EA7124FQ35143513-BF1FE5F3-FA30-47B5-8EA7-D247236CE0EDQ36513782-462C52E7-7E49-4645-B19F-BC094B973C1AQ36619075-8E535573-DCB3-436B-87A2-855239E5748AQ36673465-80C4A424-5CF6-4E12-96BD-729B04E22F03Q36963203-2EB11075-4784-490C-8A6D-91057C5A9410Q37048434-93EA203F-EC4A-4C25-BA92-B55373957638Q37117624-45D02393-E43E-4BA6-9AB6-CEA723A86863Q37370051-D9D1DF68-8288-440B-9668-BD9088C5EE91Q37406818-20B030FB-CF75-4486-9D21-29C97B789C24Q37626783-0B6369AF-EA43-4563-B114-86AE0D5B538EQ37812870-588D71A6-EDAE-4BE6-A548-537A0179D51AQ38219408-053FFDEF-9E4F-4410-9DF2-B54BEA708572Q39045031-98AF6D2D-194F-44FE-A808-3A50CA24F3ACQ41104743-100697CF-2BAC-4B3B-8D1F-3E65A96E6F9EQ41360812-ED16EDBF-2E32-498D-A18B-43A9DB262B7DQ41557109-3C6217D4-D77D-4465-857B-1F61E1C0DBDCQ41827707-A5B3828C-15D0-4CE3-8D8F-AEC6EFF52E45Q42008119-3BCC535E-A53E-4BC9-9E79-F1F0F3CB2C4AQ42183935-E1827096-5E78-4C51-B4E9-D5F1126C57ACQ43113067-C73F6502-E5A6-41FB-8854-69F6D996B16EQ47110039-246DA692-1722-47FE-970A-A75406F389E3Q49641900-C6766925-9E43-423E-B839-D9F4208B81EDQ51804210-26FF2767-4B91-42F6-B091-310716B72588
P2860
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Immunophenotypic characterizat ...... ween MGUS and multiple myeloma
@ast
Immunophenotypic characterizat ...... ween MGUS and multiple myeloma
@en
Immunophenotypic characterizat ...... ween MGUS and multiple myeloma
@nl
type
label
Immunophenotypic characterizat ...... ween MGUS and multiple myeloma
@ast
Immunophenotypic characterizat ...... ween MGUS and multiple myeloma
@en
Immunophenotypic characterizat ...... ween MGUS and multiple myeloma
@nl
prefLabel
Immunophenotypic characterizat ...... ween MGUS and multiple myeloma
@ast
Immunophenotypic characterizat ...... ween MGUS and multiple myeloma
@en
Immunophenotypic characterizat ...... ween MGUS and multiple myeloma
@nl
P2093
P2860
P1476
Immunophenotypic characterizat ...... ween MGUS and multiple myeloma
@en
P2093
Caballero D
Escribano L
González M
Hernández J
López-Berges C
Ocqueteau M
P2860
P304
P407
P577
1998-06-01T00:00:00Z